verapamil has been researched along with Hyperprolactinemia in 8 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil stimulation test was previously investigated as a tool for differential diagnosis of hyperprolactinemia, but with conflicting results." | 7.76 | Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect. ( Dagdelen, S; Usman, A, 2010) |
| "To describe a patient with an incidental pituitary lesion who experienced verapamil-induced hyperprolactinemia." | 7.69 | Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma. ( Aron, DC; Dombrowski, RC; Romeo, JH, 1995) |
| "Verapamil has been associated with hyperprolactinaemia, but there have been no population-based studies." | 7.69 | Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men. ( Aron, DC; Dombrowski, R; Fuehrer, S; Kwak, YS; Romeo, JH, 1996) |
| "We studied the effect of acute administration of the calcium-channel blocker verapamil (VER) in 27 patients with tumoral hyperprolactinemia ([THPRL] prolactinomas and pseudoprolactinomas)." | 5.09 | Verapamil acute administration: a new dynamic test in hyperprolactinemic states. ( Barbaro, D; Bombara, M; Carnesecchi, C; Faggionato, F; Falciani, C; La Gioia, A; Loni, G; Palla, A; Pallini, S, 1999) |
| "Verapamil stimulation test was previously investigated as a tool for differential diagnosis of hyperprolactinemia, but with conflicting results." | 3.76 | Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect. ( Dagdelen, S; Usman, A, 2010) |
| "To describe a patient with an incidental pituitary lesion who experienced verapamil-induced hyperprolactinemia." | 3.69 | Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma. ( Aron, DC; Dombrowski, RC; Romeo, JH, 1995) |
| "Verapamil has been associated with hyperprolactinaemia, but there have been no population-based studies." | 3.69 | Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men. ( Aron, DC; Dombrowski, R; Fuehrer, S; Kwak, YS; Romeo, JH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dagdelen, S | 1 |
| Usman, A | 1 |
| Krysiak, R | 1 |
| Okopieh, B | 1 |
| Herman, ZS | 1 |
| Knoepfelmacher, M | 1 |
| Villares, SM | 1 |
| Nicolau, W | 1 |
| Germek, OO | 1 |
| Lerário, AC | 1 |
| Wajchenberg, BL | 1 |
| Liberman, B | 1 |
| Kelley, SR | 1 |
| Kamal, TJ | 1 |
| Molitch, ME | 1 |
| Dombrowski, RC | 1 |
| Romeo, JH | 2 |
| Aron, DC | 2 |
| Dombrowski, R | 1 |
| Kwak, YS | 1 |
| Fuehrer, S | 1 |
| Barbaro, D | 1 |
| Faggionato, F | 1 |
| Pallini, S | 1 |
| Carnesecchi, C | 1 |
| Palla, A | 1 |
| Bombara, M | 1 |
| Falciani, C | 1 |
| La Gioia, A | 1 |
| Loni, G | 1 |
| Ortega Calvo, M | 1 |
| Macías Pérez, V | 1 |
| Merino Kolly, MN | 1 |
| Torelló Iserte, J | 1 |
1 trial available for verapamil and Hyperprolactinemia
| Article | Year |
|---|---|
Verapamil acute administration: a new dynamic test in hyperprolactinemic states.
Topics: Administration, Oral; Calcium Channel Blockers; Chemistry, Pharmaceutical; Humans; Hyperprolactinemi | 1999 |
7 other studies available for verapamil and Hyperprolactinemia
| Article | Year |
|---|---|
Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect.
Topics: Adult; Biomarkers; Case-Control Studies; Diagnosis, Differential; Female; Humans; Hyperprolactinemia | 2010 |
[Verapamil-induced hyperprolactinemia--a case report].
Topics: Adult; Bromocriptine; Calcium Channel Blockers; Female; Galactorrhea; Hormone Antagonists; Humans; H | 2005 |
Calcium and prolactin secretion in humans: effects of the channel blocker, verapamil, in the spontaneous and drug-induced hyperprolactinemia.
Topics: Adult; Calcium; Female; Humans; Hyperprolactinemia; Male; Prolactin; Prolactinoma; Sulpiride; Thyrot | 1994 |
Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia.
Topics: Adolescent; Adult; Calcium Channel Blockers; Carbidopa; Dopamine; Female; Humans; Hyperprolactinemia | 1996 |
Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma.
Topics: Aged; Calcium Channel Blockers; Erectile Dysfunction; Humans; Hyperprolactinemia; Magnetic Resonance | 1995 |
Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men.
Topics: Aged; Calcium Channel Blockers; Cross-Sectional Studies; Humans; Hyperprolactinemia; Longitudinal St | 1996 |
[Hyperprolactinemia secondary to hypotensive treatment with verapamil].
Topics: Adult; Female; Humans; Hyperprolactinemia; Vasodilator Agents; Verapamil | 2000 |